SCHEMBL18597903

SCHEMBL18597903

Cc1noc(-c2ccc(Br)cc2)c1C(O)C(=O)NC(C)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
LMNA P02545 2/20 0.46
STAT3 P40763 2/20 0.46
LPAR1 Q92633 3/20 0.45
LPAR3 Q9UBY5 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.43
ABCC3 O15438 1/20 0.41
ABCC4 O15439 1/20 0.41
ABCB11 O95342 1/20 0.41
CYP2C8 P10632 1/20 0.41
CYP2C9 P11712 1/20 0.41
ABCB4 P21439 1/20 0.41
ABCC2 Q92887 1/20 0.41
SLCO1B3 Q9NPD5 1/20 0.41
SLCO1B1 Q9Y6L6 1/20 0.41
TSHR P16473 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
POLB P06746 1/20 0.40
THRB P10828 1/20 0.40
MMP9 P14780 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7770 1.00 ALDH1A1 (0.53) ALDH1A1LMNASTAT3LPAR1LPAR3
SCHEMBL13719969 0.87 ALDH1A1 (0.51) ALDH1A1LMNASTAT3LPAR1LPAR3
SCHEMBL18597898 0.84 LPAR1 (0.59) ALDH1A1LMNASTAT3LPAR1LPAR3
SCHEMBL14703 0.84 LPAR1 (0.59) ALDH1A1LMNASTAT3LPAR1LPAR3
SCHEMBL6783 0.80 GAA (0.46) ALDH1A1LMNASTAT3LPAR1LPAR3
SCHEMBL7475 0.80 PTPN1 (0.40) ALDH1A1LPAR1LPAR3SMN1; SMN2ABCC3
SCHEMBL6812 0.79 LPAR1 (0.50) STAT3LPAR1LPAR3ABCC3ABCC4
SCHEMBL6377 0.79 CNR1 (0.42) SMN1; SMN2CYP2C9TSHRPOLB
SCHEMBL7105 0.78 ALDH1A1 (0.53) ALDH1A1LMNASTAT3LPAR1LPAR3
SCHEMBL7013 0.76 ALDH1A1 (0.50) ALDH1A1LMNASTAT3LPAR1LPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-B1 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS INC (US) 2017-03-08 EP disclosed